These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 6574995)

  • 1. Preliminary echocardiographic and polygraphic evaluation of cardiac toxicity of 4'-epi-doxorubicin.
    Villani F; Comazzi R; Lacaita G; Genitoni V; Guindani A; Martini A
    Int J Clin Pharmacol Ther Toxicol; 1983 Apr; 21(4):203-8. PubMed ID: 6574995
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical evaluation of the cardiac toxicity of 4'-deoxy-doxorubicin.
    Villani F; Galimberti M; Comazzi R; Crippa F; Bonfante V; Ferrari L; Pacciarini MA
    Int J Clin Pharmacol Ther Toxicol; 1988 Apr; 26(4):185-9. PubMed ID: 3403095
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preliminary evaluation of myocardial toxicity of 4'-deoxydoxorubicin: experimental and clinical results.
    Villani F; Comazzi R; Genitoni V; Lacaita G; Guindani A; Crippa F; Monti E; Piccinini F; Rozza A; Lanza E
    Drugs Exp Clin Res; 1985; 11(3):223-31. PubMed ID: 3836127
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cardiac troponin I: is it a marker to detect cardiotoxicity in children treated with doxorubicin?
    Köseoğlu V; Berberoğlu S; Karademir S; Kismet E; Yurttutan N; Demirkaya E; Sungur M; Alehan D
    Turk J Pediatr; 2005; 47(1):17-22. PubMed ID: 15884624
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A phase I/II study of sequential doxorubicin and paclitaxel in the treatment of advanced breast cancer.
    Amadori D; Frassineti GL; Zoli W; Milandri C; Tienghi A; Ravaioli A; Gentile A; Salzano E
    Semin Oncol; 1996 Oct; 23(5 Suppl 11):16-22. PubMed ID: 8893894
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phase I study of paclitaxel and epirubicin in patients with metastatic breast cancer: a preliminary report on safety.
    Catimel G; Spielmann M; Dieras V; Kayitalire L; Pouillart P; Guastalla JP; Soler-Michel P; Graffand N; Garet F; Dumortier A; Pellae-Cosset B; Chazard M
    Semin Oncol; 1996 Feb; 23(1 Suppl 1):24-7. PubMed ID: 8629032
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phase II study of weekly low-dose 4'-epi-doxorubicin in advanced postmenopausal breast cancer.
    Jones WG; Mattsson W
    Cancer Treat Rep; 1984 Apr; 68(4):675-7. PubMed ID: 6585271
    [TBL] [Abstract][Full Text] [Related]  

  • 8. New insight into epirubicin cardiac toxicity: competing risks analysis of 1097 breast cancer patients.
    Ryberg M; Nielsen D; Cortese G; Nielsen G; Skovsgaard T; Andersen PK
    J Natl Cancer Inst; 2008 Aug; 100(15):1058-67. PubMed ID: 18664656
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quantitative experimental evaluation of adriamycin cardiotoxicity in the mouse.
    Bertazzoli C; Bellini O; Magrini U; Tosana MG
    Cancer Treat Rep; 1979; 63(11-12):1877-83. PubMed ID: 526920
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cardiotoxicity of epirubicin and doxorubicin: assessment by endomyocardial biopsy.
    Torti FM; Bristow MM; Lum BL; Carter SK; Howes AE; Aston DA; Brown BW; Hannigan JF; Meyers FJ; Mitchell EP
    Cancer Res; 1986 Jul; 46(7):3722-7. PubMed ID: 3458531
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of cardiotoxicity of pirarubicin, epirubicin and doxorubicin in the rat.
    Hirano S; Wakazono K; Agata N; Iguchi H; Tone H
    Drugs Exp Clin Res; 1994; 20(4):153-60. PubMed ID: 7813387
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Annexin V imaging of acute doxorubicin cardiotoxicity (apoptosis) in rats.
    Bennink RJ; van den Hoff MJ; van Hemert FJ; de Bruin KM; Spijkerboer AL; Vanderheyden JL; Steinmetz N; van Eck-Smit BL
    J Nucl Med; 2004 May; 45(5):842-8. PubMed ID: 15136635
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of biotransformation in anthracycline-induced cardiotoxicity in mice.
    de Jong J; Schoofs PR; Snabilié AM; Bast A; van der Vijgh WJ
    J Pharmacol Exp Ther; 1993 Sep; 266(3):1312-20. PubMed ID: 8371139
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of doxorubicin and its analogue mitoxantrone on cardiac muscle and on serum lipids: an experimental study.
    Koutinos G; Stathopoulos GP; Dontas I; Perrea-Kotsarelis D; Couris E; Karayannacos PE; Deliconstantinos G
    Anticancer Res; 2002; 22(2A):815-20. PubMed ID: 12014656
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Monohydroxyethylrutoside, a dose-dependent cardioprotective agent, does not affect the antitumor activity of doxorubicin.
    van Acker SA; Boven E; Kuiper K; van den Berg DJ; Grimbergen JA; Kramer K; Bast A; van der Vijgh WJ
    Clin Cancer Res; 1997 Oct; 3(10):1747-54. PubMed ID: 9815559
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phase II trial of 4'-epi-doxorubicin in metastatic melanoma.
    Torti FM; Porzig KJ; Gandara DR; Volberding P; Mitchell E; Meyers FJ; Kohler M; Gribble M
    Cancer Treat Rep; 1984 Dec; 68(12):1509-10. PubMed ID: 6595059
    [No Abstract]   [Full Text] [Related]  

  • 17. Phase II evaluation of 4'-epi-doxorubicin in patients with metastatic colorectal carcinoma.
    Ajani JA; Kanojia MD; Bodey GP
    Cancer Treat Rep; 1984 Dec; 68(12):1507-8. PubMed ID: 6595058
    [No Abstract]   [Full Text] [Related]  

  • 18. 4'-Epidoxorubicin to re-explore anthracycline degradation in cardiomyocytes.
    Menna P; Salvatorelli E; Minotti G
    Chem Res Toxicol; 2009 Jun; 22(6):978-83. PubMed ID: 19397277
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Comparative study of the cardiotoxicity of the anthracycline antibiotics, carminomycin and adriamycin, in white mice].
    Gol'dberg LE; Shepelevtseva NG; Belova IP; Vertogradova TP
    Antibiotiki; 1976 Dec; 21(12):1106-13. PubMed ID: 1020945
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reduction of the cardiotoxicity of doxorubicin in rabbits and dogs by encapsulation in long-circulating, pegylated liposomes.
    Working PK; Newman MS; Sullivan T; Yarrington J
    J Pharmacol Exp Ther; 1999 May; 289(2):1128-33. PubMed ID: 10215696
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.